Julian Baumeister

Aachen, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

JAK2V617F-positive clonal hematopoiesis in germline BRCA1 versus BRCA2 mutation carriers.

JAK2V617F-positive clonal hematopoiesis in germline BRCA1 versus BRCA2 mutation carriers.

Journal: Leukemia
Published: March 24, 2026

Glucose transport dependency defines a therapeutic vulnerability in JAK2V617F-driven myeloproliferative neoplasms.

Glucose transport dependency defines a therapeutic vulnerability in JAK2V617F-driven myeloproliferative neoplasms.

Journal: Cell communication and signaling : CCS
Published: February 27, 2026

Frequent and clinically relevant germline DNA repair gene variants in young and familial myeloproliferative neoplasms.

Frequent and clinically relevant germline DNA repair gene variants in young and familial myeloproliferative neoplasms.

Journal: Blood cancer journal
Published: September 18, 2025

Designing and modeling nanomedicines towards image-guided drug delivery in hematological malignancies.

Designing and modeling nanomedicines towards image-guided drug delivery in hematological malignancies.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 24, 2024

Asciminib antagonizes transplantable BCR::ABL1-positive lymphoid blast crisis in vivo by targeting malignant stem cells.

Asciminib antagonizes transplantable BCR::ABL1-positive lymphoid blast crisis in vivo by targeting malignant stem cells.

Journal: Leukemia
Published: March 25, 2024

Deciphering the complex clonal heterogeneity of polycythemia vera and the response to interferon alfa.

Deciphering the complex clonal heterogeneity of polycythemia vera and the response to interferon alfa.

Journal: Blood advances
Published: January 08, 2024

Oncogenic Calreticulin Induces Immune Escape by Stimulating TGFβ Expression and Regulatory T-cell Expansion in the Bone Marrow Microenvironment.

Oncogenic Calreticulin Induces Immune Escape by Stimulating TGFβ Expression and Regulatory T-cell Expansion in the Bone Marrow Microenvironment.

Journal: Cancer research
Published: November 10, 2023

Calreticulin and JAK2V617F driver mutations induce distinct mitotic defects in myeloproliferative neoplasms.

Calreticulin and JAK2V617F driver mutations induce distinct mitotic defects in myeloproliferative neoplasms.

Journal: Scientific reports
Published: October 23, 2023

Exploiting Synthetic Lethality between Germline BRCA1 Haploinsufficiency and PARP Inhibition in JAK2V617F-Positive Myeloproliferative Neoplasms.

Exploiting Synthetic Lethality between Germline BRCA1 Haploinsufficiency and PARP Inhibition in JAK2V617F-Positive Myeloproliferative Neoplasms.

Journal: International journal of molecular sciences
Published: October 18, 2023

Cellular aging is accelerated in the malignant clone of myeloproliferative neoplasms.

Cellular aging is accelerated in the malignant clone of myeloproliferative neoplasms.

Journal: Blood cancer journal
Published: August 15, 2023

Engineering Mesoscopic 3D Tumor Models with a Self-Organizing Vascularized Matrix.

Engineering Mesoscopic 3D Tumor Models with a Self-Organizing Vascularized Matrix.

Journal: Advanced materials (Deerfield Beach, Fla.)
Published: April 05, 2023

Clonogenic assays improve determination of variant allele frequency of driver mutations in myeloproliferative neoplasms.

Clonogenic assays improve determination of variant allele frequency of driver mutations in myeloproliferative neoplasms.

Journal: Annals of hematology
Published: June 24, 2022
Showing 1-12 of 22

Last Updated: 09/26/2026